Moody's assigns Amgen notes Baa1

Moody's Investors Service said it assigned a Baa1 rating to Amgen Inc.’s new senior unsecured note offering.

There are no changes to Amgen's other ratings including the Baa1 senior unsecured long-term rating., the agency said.

Amgen will use the proceeds for general corporate purposes.

The outlook is stable.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.